Calculated Parenteral Initial Treatment of Bacterial Infections: Bone and Joint Infections

Overview

Journal GMS Infect Dis

Specialty Infectious Diseases

Date 2020 May 7

PMID 32373435

Citations 4

Authors

Mathias G Vossen

Rainer Gattringer

Florian Thalhammer

Matthias Militz

Gunnar Hischebeth

Affiliations

Soon will be listed here.

Abstract

This is the 10 chapter of the guideline "Calculated initial parenteral treatment of bacterial infections in adults - update 2018" in the 2 updated version. The German guideline by the Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. (PEG) has been translated to address an international audience. This chapter deals with bacterial Infections of bones, joints and prosthetic joints. One of the most pressing points is that after an initial empirical therapy a targeted antimicrobial which penetrates well to the point of infection and is tolerated well over the usually long duration of the therapy is chosen.

Citing Articles

Antibiotics with antibiofilm activity - rifampicin and beyond.

Ferreira L, Pos E, Nogueira D, Ferreira F, Sousa R, Abreu M Front Microbiol. 2024; 15:1435720.

PMID: 39268543 PMC: 11391936. DOI: 10.3389/fmicb.2024.1435720.

[50/m-Painful redness and swelling after surgical fracture stabilization : Preparation for the medical specialist examination: part 80].

Hackl S, Herbolzheimer M, Militz M Unfallchirurg. 2021; 124(Suppl 1):226-231.

PMID: 33765188 DOI: 10.1007/s00113-021-00991-y.

S2k guideline "Calculated parenteral initial treatment of bacterial infections in adults - update 2018", 2 updated version: Foreword.

Bodmann K, Grabein B, Kresken M GMS Infect Dis. 2020; 8:Doc20.

PMID: 32373445 PMC: 7186796. DOI: 10.3205/id000064.

Calculated parenteral initial treatment of bacterial infections: Infections in the ear, nose, throat and mouth and jaw area.

Olzowy B, Al-Nawas B, Havel M, Karbach J, Muller R GMS Infect Dis. 2020; 8:Doc14.

PMID: 32373439 PMC: 7186809. DOI: 10.3205/id000058.

References

Roblot F, Besnier J, Juhel L, Vidal C, Ragot S, Bastides F . Optimal duration of antibiotic therapy in vertebral osteomyelitis. Semin Arthritis Rheum. 2007; 36(5):269-77. DOI: 10.1016/j.semarthrit.2006.09.004. View

Zimmerli W, Trampuz A, Ochsner P . Prosthetic-joint infections. N Engl J Med. 2004; 351(16):1645-54. DOI: 10.1056/NEJMra040181. View

Esposito S, Leone S, Noviello S, Ianniello F, Fiore M, Russo M . Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study. J Chemother. 2007; 19(4):417-22. DOI: 10.1179/joc.2007.19.4.417. View

Borens O, Yusuf E, Steinrucken J, Trampuz A . Accurate and early diagnosis of orthopedic device-related infection by microbial heat production and sonication. J Orthop Res. 2013; 31(11):1700-3. DOI: 10.1002/jor.22419. View

Bogut A, Niedzwiadek J, Strzelec-Nowak D, Blacha J, Mazurkiewicz T, Marczynski W . Infectious prosthetic hip joint loosening: bacterial species involved in its aetiology and their antibiotic resistance profiles against antibiotics recommended for the therapy of implant-associated infections. New Microbiol. 2014; 37(2):209-18. View

Matthews P, Berendt A, McNally M, Byren I . Diagnosis and management of prosthetic joint infection. BMJ. 2009; 338:b1773. DOI: 10.1136/bmj.b1773. View

Fierer J . Dosing rifampin. Clin Infect Dis. 2013; 57(1):161. DOI: 10.1093/cid/cit186. View

Spellberg B, Lipsky B . Systemic antibiotic therapy for chronic osteomyelitis in adults. Clin Infect Dis. 2011; 54(3):393-407. PMC: 3491855. DOI: 10.1093/cid/cir842. View

Garcia-Lechuz J, Bouza E . Treatment recommendations and strategies for the management of bone and joint infections. Expert Opin Pharmacother. 2009; 10(1):35-55. DOI: 10.1517/14656560802611766. View

10.

Lopez-Garcia B, Luque S, Roberts J, Grau S . Pharmacokinetics and preliminary safety of high dose linezolid for the treatment of Gram-positive bacterial infections. J Infect. 2015; 71(5):604-7. DOI: 10.1016/j.jinf.2015.06.007. View

11.

Moenster R, Linneman T, Call W, Kay C, McEvoy T, Sanders J . The potential role of newer gram-positive antibiotics in the setting of osteomyelitis of adults. J Clin Pharm Ther. 2013; 38(2):89-96. DOI: 10.1111/jcpt.12030. View

12.

Sanchez E, Mendes R, Sader H, Allison G . In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis. J Antimicrob Chemother. 2016; 71(6):1736-8. PMC: 4867098. DOI: 10.1093/jac/dkw001. View

13.

Cobo J, Lora-Tamayo J, Euba G, Jover-Saenz A, Palomino J, Del Toro M . Linezolid in late-chronic prosthetic joint infection caused by gram-positive bacteria. Diagn Microbiol Infect Dis. 2013; 76(1):93-8. DOI: 10.1016/j.diagmicrobio.2013.02.019. View

14.

Tsuji B, Bulitta J, Brown T, Forrest A, Kelchlin P, Holden P . Pharmacodynamics of early, high-dose linezolid against vancomycin-resistant enterococci with elevated MICs and pre-existing genetic mutations. J Antimicrob Chemother. 2012; 67(9):2182-90. DOI: 10.1093/jac/dks201. View

15.

Zimmerli W, Widmer A, Blatter M, Frei R, Ochsner P . Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA. 1998; 279(19):1537-41. DOI: 10.1001/jama.279.19.1537. View

16.

Scheffer D, Hofmann S, Pietsch M, Wenisch C . [Infections in orthopedics and traumatology. Pathogenesis and therapy]. Orthopade. 2008; 37(7):709-18. DOI: 10.1007/s00132-008-1301-x. View

17.

Bernard L, Dinh A, Ghout I, Simo D, Zeller V, Issartel B . Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial. Lancet. 2014; 385(9971):875-82. DOI: 10.1016/S0140-6736(14)61233-2. View

18.

Kazimoglu C, Yalcin N, Onvural B, Akcay S, Agus H . Debridement, antibiotics, irrigation, and retention (DAIR) of the prosthesis after hip hemiarthroplasty infections. Does it work?. Int J Artif Organs. 2015; 38(8):454-60. DOI: 10.5301/ijao.5000430. View

19.

Corti N, Sennhauser F, Stauffer U, Nadal D . Fosfomycin for the initial treatment of acute haematogenous osteomyelitis. Arch Dis Child. 2003; 88(6):512-6. PMC: 1763134. DOI: 10.1136/adc.88.6.512. View

20.

Osmon D, Berbari E, Berendt A, Lew D, Zimmerli W, Steckelberg J . Reply to Eisen and Denholm, Dauchy et al, Fierer, and Nguyen and Jones. Clin Infect Dis. 2013; 57(1):162-4. DOI: 10.1093/cid/cit189. View